Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wrist and ankle acupuncture for acute shingles pain
ChiCTR2300071795Phase 3Not yet recruiting
- Sponsor
- Mianyang Central Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of caffeine in herpes zoster (HZ) (2 arms), sponsored by Mianyang Central Hospital. Primary endpoints: Therapeutic effect and Pain score. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
caffeine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2300071795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071795.